Caplight Directory>Companies>Vakona-preview>Vakona


Vakona

Vakona

Private
UmeåHealthcare & Life Scienceshttps://vakona.se

Last Round

VC Round

Apr 28, 2025

Total Funding Raised

$1.75M

Company Overview

Vakona is a pharmaceutical company developing a new approach to treating acne without the use of antibiotics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

acne treatmentantibiotic-free treatmentbiofilm degradationtopical treatmentacne vulgarispre-clinical biotechenzyme-based therapyskin microbiomebiofilm disruptordrug developmentbiologicsdermatologyprocess developmentdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vakona Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vakona Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 28, 2025
VC RoundMar 29, 2023
SeedNov 8, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Gabriella Persson

CEO

Executive Team

Vakona Investors

Notable investors and investment history

InvestorRounds
Phase2Phase BiopharmaSeed, VC Round
STOAF III SciTechSeed, VC Round
Partnerinvest NorrSeed, VC Round
View all Investors

Vakona Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vakona Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vakona's valuation, stock price, and market status.

Firmographic Details

HeadquartersUmeå
Employee Range6
Year Founded2020
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.